European Archives - Page 966 of 981 - European Medical Journal

Continue
EMJ
9 May 2014

New Method Sneaks Drugs into Cancer Cells before Triggering Release

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before…
EMJ
5 May 2014

Robotic Radical Cystectomy for Bladder Cancer: Current Perspectives

The most effective local treatment of muscle invasive bladder cancer and non-invasive, high-grade bladder tumours that recur or progress despite…
EMJ
3 May 2014

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

Neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer was introduced several years ago. Despite the evidence supporting its use in clinical…
EMJ
24 Apr 2014

Aspirin Can Reduce Colorectal Cancer Risks for Those with Specific Gene

The humble aspirin may have just added another beneficial effect beyond its ability to ameliorate headaches and reduce the risk of heart attacks…
EMJ
15 Apr 2014

Enzyme Revealed as Promising Target to Treat Asthma and Cancer

In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells…
EMJ
11 Apr 2014

Review of Testosterone-Containing Medicines Started

The European Medicines Agency has started a review of testosterone-containing medicines, mainly used in men who do not produce enough testosterone…
EMJ
10 Apr 2014

International Coeliac Day 16 May 2014

As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.
EMJ
8 Apr 2014

Caffeine against Alzheimer’s Disease

As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the…
EMJ
2 Mins
1 Apr 2014

Adverse Events

A year after I graduated, I was working in an emergency department when one of my colleagues killed someone.
EMJ
30 Mar 2014

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14

Analysis of EUROMAX and HORIZONS-AMI Trials of the Medicines Company’s Angiomax(R) (Bivalirudin) Presented at ACC.14